In the TME, CXCL13 is a hallmark of tertiary lymphoid structures (TLSs) (Figure 3) [288], which facilitate antigen presentation and support effective anti-tumour T-cell responses [289]. The gene discussed is CXCL13; the disease is neoplasm.